ACTU Actuate Therapeutics: Company Short-Term Debts

Symbol and logo of brand Actuate Therapeutics, Inc. (ACTU)

This daily price action for Actuate Therapeutics, Inc. (ACTU), a company specializing in oncology therapies, reflects the 0.00 metric. Management is focused on developing cutting-edge drugs that target cellular mechanisms, leveraging a robust scientific foundation. The business operates within its own cycle, independent of external economic shocks, which transforms these biotechnologies into a resilient defensive asset.

ACTU Actuate Therapeutics Inc. Company Short-Term Loans and Borrowings (08/14/2024 - 11/01/2026)

ACTU (Actuate Therapeutics Inc): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Actuate Therapeutics|ACTU - Consensus Target
- company stock capitalization data:
Market Capitalization Actuate Therapeutics, Inc.|ACTU - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Actuate Therapeutics|ACTU - Accounting Value of Company|Market Cap to Net Assets Ratio actuatetherapeutics.com|ACTU - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Actuate Therapeutics, Inc.|ACTU - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Actuate Therapeutics, Inc.|ACTU - Company Aggregate Debts|Debt to Book Capitalization Ratio Actuate Therapeutics, Inc.|ACTU - Company Long-Term Loans and Borrowings|Company Short-Term Debts Actuate Therapeutics|Quick Ratio actuatetherapeutics.com
- earnings and multiples data:
ACTU - Net Profit
Analysis of all company metrics:ACTU - Actuate Therapeutics
Manufactured products of actuatetherapeutics.com

Actuate Therapeutics, Inc. (ACTU) focuses on developing an innovative GSK-3beta inhibitor for the treatment of pancreatic cancer. The trend in current financial liabilities tracks short-term accounts payable and taxes in real time. This metric measures immediate liquidity, identifying the risk of working capital shortages prior to the publication of financial statements. The stability of this indicator is critical for maintaining R&D potential until the company achieves pricing power upon the commercialization of elraglusib. This chart allows for an assessment of the business's resilience to sudden financial shocks.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Citius Oncology Inc CTOR|Company Short-Term Debts HURA|Company Short-Term Debts protaratx.com (TARA)|Company Short-Term Debts FATE (Fate Therapeutics)|WHWK - Company Current Liabilities|TCRX: Company Current Liabilities|Champions Oncology - Amount of Current Liabilities|XBIT (xbiotech.com) - Company Current Liabilities|CEL-SCI (CVM) - Company Short-Term Debts|OSTX (OS Therapies) - Company Short-Term Debts|Company Short-Term Debts Radiopharm Theranostics Ltd|Company Current Liabilities ARTV (Artiva Biotherapeutics, Inc.)|Amount of Current Liabilities ANL|Company Short-Term Debts VERU (Veru Inc.)|tempesttx.com (TPST) - Short-Term Debt|XLO: Company Current Liabilities|Company Short-Term Loans and Borrowings RENB (Renovaro Inc.)|MURA (muraloncology.com) - Company Current Liabilities|KAPA: Amount of Current Liabilities|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|GDTC: Company Short-Term Loans and Borrowings|Company Short-Term Debts CRIS|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|Company Short-Term Loans and Borrowings ADVB|Genprex, Inc. - Company Short-Term Debts|CLDI - Company Short-Term Debts|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Current Liabilities XBIO (Xenetic Biosciences, Inc.)|SLRX (Salarius) - Company Short-Term Debts|Short-Term Debt Kitov Pharma PPBT|Company Current Liabilities AONC (American Oncology Network)|Company Short-Term Debts beigene.com (BGNE)|Checkpoint Therapeutics, Inc. - Company Current Liabilities|Amount of Current Liabilities ELEV (Elevation Oncology Inc.)|iCAD Corp - Company Short-Term Debts|Short-Term Debt Volume Ikena Oncology, Inc. IKNA|NTBL: Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|Company Short-Term Debt MorphoSys|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Current Liabilities AAPGV (Ascentage Pharma Group Ltd)